Albion Capital Group
VC Fund
London, United Kingdom
Albion Capital Group is a VC fund in London focused on Software and Health Care. Albion typically invests £2-5m for a minority stake Series A and early Series B. They support outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market.They look at most sectors, with a particular focus on digital B2B companies – enterprise software andtechnology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive. They also invest in companies commercialising IP from University College London via the UCL Technology Fund.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 35%
- Fund size:
- $790k
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Albion Capital Group invests in
Stages Albion Capital Group invests in
Countries Albion Capital Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Impey
|
|||
| See all 13 contacts → | |||
Investment Focus
Industry
- Software 4 (24%)
- Health Care 3 (18%)
- Biotechnology 3 (18%)
- Medical 2 (12%)
- Computer 2 (12%)
Stage
- Funding Round 9 (53%)
- Venture - Series Unknown 2 (12%)
- Seed 1 (6%)
- Series A 1 (6%)
- Series B 1 (6%)
Country
- United Kingdom 8 (47%)
- United States 4 (24%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adam Chirkowski
Investment Director
|
Investment Director | Total investments: 4 | Find email | |
David Grimm
Investment Director
|
Investment Director | Total investments: 14 | Find email | |
Simon Goldman
Investment Director, UCL Technology Fund
|
Investment Director, UCL Technology Fund | Total investments: 2 | Find email | |
Andrew Elder
Partner
|
Partner | Total investments: 10 | Find email | |
|
Andrew Impey
Partner
|
Partner | Total investments: 0 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pando
|
Pando is an essential tool for teamwork and secure collaboration. It is designed to benefit anyone working in health and social care, working in a team, with a need to share sensitive information and images securely. | $5M / Seed / Jan 28, 2020 | |
G.Network
|
G.Network is the next generation communications service provider exclusively focused on Central London. The company provides affordable ultra-fast (up to 10Gbps) fibre connectivity to businesses. We are building our own ‘Fibre to the Premises’ (FTTP) fibre optic network directly into premises across the Capital meaning we can offer unrivalledquality and speeds at affordable prices. Bridging the gap between constrained copper-based connectivity and expensive, long lead time leased lines, G.Network ‘s fibre–based connectivity will transform the way you do business. | $6M / Venture - Series Unknown / Jun 14, 2017 | |
Relayware
|
Relayware is a global provider of Partner Relationship Management (PRM) software and services that produce valuable insights and bring organizations closer to their partners, providing visibility into partner effectiveness, improving training and empowering partners to reach their potential. Its software distills years of channel expertise into anautomated system that gives partners everything they need to succeed, with sales, marketing and training packs and partner portals that streamline revenue-generating processes and boost the productivity of indirect channels. | $11M / May 09, 2016 | |
Unifyr
|
Zift is the Enterprise Channel Management leader. Our ZiftONE platform enhances channel partner productivity and program profitability by automating sales, marketing, and operational processes all while integrating seamlessly with established systems and infrastructure. ZiftONE delivers all of the capabilities of Partner Relationship Management(PRM), Through Channel Marketing Automation (TCMA), and Channel Learning Management (C-LMS) in a single, innovative platform developed to maximize channel success in today’s rapidly evolving partner landscape. Zift leads the market with the ZiftONE Step-Ahead Innovation Program™ that introduced CAM Co-Pilot™ to optimize sales execution and Zift Open-Access™ to collect and connect data from across your channel. | $11M / Venture - Series Unknown / May 09, 2016 | |
Silent Herdsman
|
Silent Herdsman’s vision is to be the leading global provider of predictive analytics software for dairy and beef farmers, that improves herd performance, business efficiency and animal welfare.Crucially, the collar triggers an alert to farmers when cows are on heat, providing farmers with advanced knowledge to activate insemination at criticaltimes. This in turn enables them to produce more milk from the impregnated cows and increase their yields from each herd.The Silent Herdsman® triggers its alert via wireless technology to any mobile device such as a farmer’s mobile phone, tablet or laptop. Uniquely, its wireless technology can travel over long distances meaning it is suitable for farms hosting 100 to 20,000 cows. Its unique differentiator includes monitoring herds across large geographical distances on farms hosting several thousand beef or dairy cows. | $3.9M / Mar 24, 2014 | |
Helveta
|
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export datapoints and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon. | $1.6M / Jun 14, 2013 | |
Haemostatix
|
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation ofclots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients. | $2.9M / Nov 02, 2012 | |
|
Helveta
|
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export datapoints and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon. | $5.2M / Nov 08, 2011 | |
Red-M Group
|
Red-M Group Limited provides wireless networking solutions. It provides last mile and building to building radio based Ethernet connectivity solutions, including the delivery of wireless systems in the corporate head quarters, airports, shopping centers, stadiums, railway stations, and hospitals. The company serves health care, cellular, regulator,enterprise, transport, public sector, retail, and finance industries. Red-M Group Limited was formerly known as Red-M (Communications) Limited. The company was founded in 1999 and is based in Horsham, the United Kingdom. | $9.6M / Dec 13, 2005 | |
Xceleron
|
Xceleron believes that AMS technology and our expertise can get life-changing products quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration.Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered humanmicrodose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials.Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development. | $2.5M / Series B | |
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Albion Capital Group invest in?
Albion Capital Group invests primarily in Software, Health Care and Biotechnology startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 17 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Albion Capital Group?
Public channels for Albion Capital Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Albion Capital Group?
The team at Albion Capital Group includes Adam Chirkowski (Investment Director), David Grimm (Investment Director) and Simon Goldman (Investment Director, UCL Technology Fund), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
